Are diuretics harmful in the management of acute kidney injury?

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 2, 2014, Pages 155-160

  Ejaz, A Ahsan ^a   Mohandas, Rajesh ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Acute kidney injury; Diuretics; Effects

Indexed keywords

ACUTE KIDNEY INJURY; ANIMALS; DISEASE PROGRESSION; DIURETICS; HUMANS; KIDNEY; PATIENT SELECTION; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; WATER-ELECTROLYTE BALANCE;

EID: 84894091284     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000441150.17202.be     Document Type: Review

References (60)

1. Vogl A. The discovery of the organic mercurial diuretics. Am Heart J 1950; 39:881-883.
2. Lant AF. Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions-parallels and contrasts. Br J Clin Pharmacol 1987; 23:27S-41S.
3. Li F, Lei T, Zhu J, et al. A novel small-molecule thienoquinolin urea transporter inhibitor acts as a potential diuretic. Kidney Int 2013; 83:1076-1086.
4. Feig PU. Cellular mechanism of action of loop diuretics: implications for drug effectiveness and adverse effects. Am J Cardiol 1986; 57:14A-19A.
5. Lanese DM, Yuan BH, Falk SA, Conger JD. Effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am J Physiol 1991; 261:F1102-F1109.
6. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31. doi: 10.1186/cc5713.
7. Porter GA, Kloster FE, Herr RJ, et al. Relationship between alterations in renal hemodynamics during cardiopulmonary bypass and postoperative renal function. Circulation 1966; 34:1005-1021.
8. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17:1503-1520.
9. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121:4210-4221.
10. Singh P, Ricksten SE, Bragadottir G, et al. Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease. Clin Exp Pharmacol Physiol 2013; 40:138-147.
11. Albaghdadi M, Gheorghiade M, Pitt B. Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes. Eur Heart J 2011; 32:2626-2633.
12. Heyman SN, Evans RG, Rosen S, Rosenberger C. Cellular adaptive changes in AKI: mitigating renal hypoxic injury. Nephrol Dial Transplant 2012; 27:1721-1728.
13. Rosenberger C, Rosen S, Heyman SN. Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006; 33:980-988.
14. Thurau K, Boylan JW. Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med 1976; 61:308-315.
15. Heyman SN, Rosen S, Epstein FH, et al. Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int 1994; 45:981-985.
16. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995; 332:647-655.
17. Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2005; 31:79-85.
18. Redfors B, Bragadottir G, Sellgren J, et al. Acute renal failure is NOT an 'acute renal success'-a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med 2010; 38:1695-1701.
19. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000; 11:97-104.
20. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006; 333:420-425.
21. Nisula S, Kaukonen KM, Vaara ST, et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med 2013; 39:420-428.
22. Levi TM, Rocha MS, Almeida DN, et al. Furosemide is associated with acute kidney injury in critically ill patients. Braz J Med Biol Res 2012; 45:827-833.
23. VanderVoortPH,Boerma EC,KoopmansM,et al. Furosemidedoes notimprove renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med 2009; 37:533-538.
24. Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288:2547-2553.
25. Wu VC, Lai CF, Shiao CC, et al. Effect of diuretic use on 30-day postdialysis mortality in critically ill patients receiving acute dialysis. PLoS One 2012; 7:e30836.
26. Majumdar SR, Kjellstrand CM, Tymchak WJ, et al. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis 2009; 54:602-609.
27. Marenzi G, Ferrari C, Marana I, et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. JACC Cardiovasc Interv 2012; 5:90-97.
28. Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother 2013; 47:90-105.
29. Dass B, Shimada M, Kambhampati G, et al. Fluid balance as an early indicator of acute kidney injury in CV surgery. Clin Nephrol 2012; 77:438-444.
30. Kambhampati G, Ross EA, Alsabbagh MM, et al. Perioperative fluid balance and acute kidney injury. Clin Exp Nephrol 2012; 16:730-738.
31. Teixeira C, Garzotto F, Piccinni P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013; 17:R14.
32. Bouchard J, Soroko SB, Chertow GM, et al., Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009; 76:422-427.
33. Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008; 12:R74.
34. Grams ME, Estrella MM, Coresh J, et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6:966-973.
35. Ricci F, Ram?́rez T, Marmorato R, et al. Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure. P R Health Sci J 2013; 32:63-67.
36. Tarantini L, Cioffi G, Gonzini L, et al. Evolution of renal function during and after an episode of cardiac decompensation: results from the Italian survey on acute heart failure. J Cardiovasc Med (Hagerstown) 2010; 11:234-243.
37. Ng TM, Hshieh S, Chan CY, Elkayam U. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety. J Cardiovasc Pharmacol Ther 2012; 17:373-381.
38. Chawla LS, Amdur RL, Amodeo S, et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011; 79:1361-1369.
39. Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009; 119:2444-2453.
40. Jones J, Holmen J, De Graauw J, et al. Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality. Am J Kidney Dis 2012; 60:402-408.
41. Lo L J, Go AS, Chertow GM, et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009; 76:893-899.
42. Friederich-Persson M, Thorn E, Hansell P, et al. Kidney hypoxia, attributable to increased oxygen consumption, induces nephropathy independently of hyperglycemia and oxidative stress. Hypertension 2013; 62:914-919.
43. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19:43-50.
44. Perazella MA, Coca SG. Three feasible strategies to minimize kidney injury in 'incipient AKI'. Nat Rev Nephrol 2013; 9:484-490.
45. Mahesh B, Yim B, Robson D, et al. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg 2008; 33:370-376.
46. Alsabbagh MM, Asmar A, Ejaz NI, et al. Update on clinical trials for the prevention of acute kidney injury in patients undergoing cardiac surgery. Am J Surg 2013; 206:86-95.
47. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281:F887-F899.
48. Feria I, Pichardo I, Juarez P, et al. Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. Kidney Int 2003; 63:43-51
49. Mej?́a-Vilet JM, Ram?́rez V, Cruz C, et al. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 2007; 293:F78-F86.
50. Sánchez-Pozos K, Barrera-Chimal J, Garzon-Muvdi J, et al. Recovery from ischemic acute kidney injury by spironolactone administration. Nephrol Dial Transplant 2012; 27:3160-3169.
51. Barrera-Chimal J, Perez-Villalva R, Rodr?́guez-Romo R, et al. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney Int 2013; 83:93-103
52. Boesby L, Elung-Jensen T, Klausen TW, et al. Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in nondiabetic chronic kidney disease. A randomized cross-over study. PLoS One 2011; 6:e26904.
53. Huang CL, Lewicki J, Johnson LK, Cogan MG. Renal mechanism of action of rat atrial natriuretic factor. J Clin Invest 1985; 75:769-773.
54. Ejaz AA, Martin TD, Johnson RJ, et al. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg 2009; 138:959-964.
55. Bagshaw SM, Delaney A, Haase M, et al. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 2007; 9:60-68.
56. Kellum JA. Systematic review: the use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care 1997; 1:53.
57. Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008; 148:284-294.
58. Patel NN, Rogers CA, AngeliniGD, MurphyGJ. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev 2011; 16:553-567.
59. Joannidis M, Druml W, Forni LG, et al. Prevention of acute kidney injury and protectionofrenalfunctionintheintensivecareunit.ExpertopinionoftheWorking Group for Nephrology, ESICM. Intensive Care Med 2010; 36:392-411.
60. KDIGO Clinical practice guideline for acute kidney injury. Kidney Int 2012; 2:1-138